Patents by Inventor Yann Godet

Yann Godet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Melanoma antigen peptide and uses thereof
    Patent number: 8975371
    Abstract: The present invention relates to novel melanoma antigen peptides and specific T lymphocytes directed to said peptides and the use thereof for treating melanoma.
    Type: Grant
    Filed: November 21, 2013
    Date of Patent: March 10, 2015
    Assignees: INSERM (Institut National de la Sante et de la Recherche Medicale), Universite de Nantes, Chu Nantes
    Inventors: Nathalie Labarriere, Agnes Moreau-Aubry, Yann Godet
  • Novel Melanoma Antigen Peptide and Uses Thereof
    Publication number: 20140088290
    Abstract: The present invention relates to novel melanoma antigen peptides and specific T lymphocytes directed to said peptides and the use thereof for treating melanoma.
    Type: Application
    Filed: November 21, 2013
    Publication date: March 27, 2014
    Applicants: INSERM (Institut National de la Sante et de la Recherche Medicale), Chu Nantes, Universite de Nantes
    Inventors: Nathalie Labarriere, Agnes Moreau-Aubry, Yann Godet
  • Melanoma antigen peptide and uses thereof
    Patent number: 8604166
    Abstract: The present invention relates to novel melanoma antigen peptides and specific T lymphocytes directed to said peptides and the use thereof for treating melanoma.
    Type: Grant
    Filed: September 2, 2009
    Date of Patent: December 10, 2013
    Assignees: Inserm (Institut National de la Sante et de la Recherche Medicale), Universite de Nantest, Chu Nantes
    Inventors: Nathalie Labarriere, Agnes Moreau-Aubry, Yann Godet
  • Novel Melanoma Antigen Peptide and Uses Thereof
    Publication number: 20110212098
    Abstract: The present invention relates to novel melanoma antigen peptides and specific T lymphocytes directed to said peptides and the use thereof for treating melanoma.
    Type: Application
    Filed: September 2, 2009
    Publication date: September 1, 2011
    Applicants: UNIVERSITE DE NANTES, CHU NANTES, INSERM (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Nathalie Labarriere, Agnes Moreau-Aubry, Yann Godet